购物车
- 全部删除
- 您的购物车当前为空
RO9021 是口服具有活力的,ATP 竞争性的 SYK 抑制剂,其 IC50=5.6 nM。
为众多的药物研发团队赋能,
让新药发现更简单!
RO9021 是口服具有活力的,ATP 竞争性的 SYK 抑制剂,其 IC50=5.6 nM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 491 | 现货 | |
5 mg | ¥ 1,120 | 现货 | |
10 mg | ¥ 1,780 | 现货 | |
25 mg | ¥ 2,850 | 现货 | |
50 mg | ¥ 3,930 | 现货 | |
100 mg | ¥ 5,290 | 现货 | |
200 mg | ¥ 7,120 | 现货 |
产品描述 | RO9021 is an orally bioavailable, novel ATP-competitive SYK inhibitor (average IC50: 5.6 nM). |
靶点活性 | Syk:5.6 nM |
体外活性 | RO9021 inhibits anti-IgM induced phosphorylation of BTK, PLCγ2, AKT and ERK, indicating that blockade of SYK kinase activity by RO9021 results in attenuation of BCR downstream signaling cascade. RO9021 selectively suppresses B-cell receptor signaling. RO9021 is a highly selective SYK inhibitor with low S-scores of 0.003 for S(99) and 0.015 for S(90), indicating that SYK is the only kinase with 99% competition with RO9021 in a total of 392 tested kinases. RO9021 also shows a similar inhibitory potency (IC50=22.8±1.7 nM) in a FcεR-mediated mast cell activation and degranulation assay [1]. |
分子量 | 355.44 |
分子式 | C18H25N7O |
CAS No. | 1446790-62-0 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||
溶解度信息 | DMSO: 3 mg/mL (8.44 mM), Sonication is recommended. | |||||||||||||||
溶液配制表 | ||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.